Works matching IS 13004948 AND DT 2025 AND VI 36 AND IP 5


Results: 9
    1
    2
    3
    4
    5

    Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG).

    Published in:
    Turkish Journal of Gastroenterology, 2025, v. 36, n. 5, p. 293, doi. 10.5152/tjg.2025.24784
    By:
    • Majidova, Nargiz;
    • Yaslıkaya, Sendag;
    • Mıldanoglu, Maral Martin;
    • Coskun, Alper;
    • Uzundal, Duygu Ercan;
    • Sahin, Taha Koray;
    • Akyildiz, Arif;
    • Akbas, Sinem;
    • Camanlı, Ufuk;
    • Sahin, Elif;
    • Atacan, Huseyin;
    • Bayrakcı, Ismail;
    • Sakalar, Teoman;
    • Cicek, Ceren Mordag;
    • Gunenc, Damla;
    • İlhan, Nurullah;
    • Unal, Olcun Umit;
    • Alan, Ozkan;
    • Hamitoglu, Buket;
    • Engin, Esra Ozen
    Publication type:
    Article
    6
    7
    8
    9